Nathan Dormer, PhD, is Director, Drug Product Development at Adare Pharma, and was previously Vice-President of Research & Development at Orbis Biosciences until Orbis was acquired by Adare in 2020. He has a decade of experience developing a variety of controlled-release solutions using microsphere techniques. He received his BS in Chemical Engineering from The University of Kansas (Lawrence, KS, US) before completing his PhD in Bioengineering with Honors from The University of Kansas with NIH-sponsored training in drug delivery and protein stability. He has authored a number of publications and book chapters relating to microsphere encapsulation and has direct experience formulating dozens of active pharmaceutical ingredients.

More contributions